-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Sigilon Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q1 2020 to Q2 2023.
- Sigilon Therapeutics, Inc. Revenues for the quarter ending June 30, 2023 was $5.9M, a 105% increase year-over-year.
- Sigilon Therapeutics, Inc. Revenues for the twelve months ending June 30, 2023 was $17.7M, a 76.8% increase year-over-year.
- Sigilon Therapeutics, Inc. annual Revenues for 2022 was $12.9M, a 34.8% increase from 2021.
- Sigilon Therapeutics, Inc. annual Revenues for 2021 was $9.6M, a 28.2% decline from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)